Exact Mass: 243.9322
Exact Mass Matches: 243.9322
Found 242 metabolites which its exact mass value is equals to given mass value 243.9322,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clodronate
Clodronate is only found in individuals that have used or taken this drug. It is a diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. [PubChem]The bisphosphonate group binds strongly to the bone mineral, hydroxyapatite. This explains the specific pharmacological action of these compounds on mineralized tissues, especially bone. The exact mechanism of action of clodronate is not known, however it is known that it does not inhibit protein isoprenylation but can be metabolized intracellularly to a β-γ-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Inhibition of the ADP/ATP translocase by the metabolite AppCCl2p is a likely route by which clodronate causes osteoclast apoptosis and inhibits bone resorption. Recently, the slime mold Dictyostelium discoideum was shown to take up bisphosphonates by pinocytosis. In these cells, clodronate, but not other pharmacologically active bisphosphonates, was incorporated into adenine nucleotides, which could potentially explain why this bisphosphonate sometimes seems to act differently than the other bisphosphonates. Clodronate, like all biphosphonates, also binds protein-tyrosine-phosphatase. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
1,2,3,5-Tetrachloro-4-methoxybenzene
Off-odour component of flour, etc. stored in contaminated jute sack
Clodronate
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
acetazolamide sodium
C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
5-(5-Bromothiazol-2-yl)-1-methyl-1H-[1,2,4]triazole
(S)-(6-BROMO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHANOL
sodium molybdate dihydrate
A hydrate that is the dihydrate form of sodium molybdate.
(R)-(+)-3-Methoxy-2-methyl-3-oxopropylzinc bromide solution
7-CHLORO-3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]THIAZINE-6-CARBOXYLIC ACID
(R)-(6-BROMO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHANOL
2-CHLORO-4-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBONYL CHLORIDE
3-(5-bromothiophen-2-yl)-5-methyl-1,2,4-oxadiazole
3-Chloro-6-methylbenzothiophene-2-carbonyl chloride
2-chloro-1-(2,3-dihydro-1,4-benzodithiin-6-yl)ethanone
3-Bromo-6-chloro-4-methyl-1H-pyrrolo[2,3-b]pyridine
3-Bromo-4-chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine
1H-Pyrrolo[2,3-b]pyridine, 4-bromo-5-chloro-2-Methyl-
2-[(4-chlorophenyl)sulfonyl]-2-hydroxyiminoacetonitrile
Methyl 2-(2,6-dichloro-3-cyanopyridin-4-yl)acetate
methyl 4,6-dichloro-1H-pyrrolo[3,2-c]pyridine-2-carboxylate
Arsonium,(2-hydroxyethyl)trimethyl-, bromide (1:1)
1H-Pyrrolo[2,3-b]pyridine-1-carboxylic acid, 4,6-dichloro-, methyl ester
1-BroMo-3-chloro-2,4,5-trifluorobenzene[3-chloro-2,4,5-trifluorobroMobenzene]
Ferric nitrilotriacetate
D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
Clodronic Acid
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
